date:Apr 27, 2012
d the company had been working with various probioptic strains for 10 years to reduce the incidence of mastitis.
It is exciting that now we are moving into the commercialisation phase with this,she said.We are in negotiations with firms in Europe and elsewhere and it can be launched in other markets via theAngelini Group.
Roux said the ingredient was suitable for formulation into different formats like pills, capsules and powder sticks.
Jose M Roset, managing director of Biosearch Life said:Over